Tumor-to-tumor metastasis: pathology and neuroimaging considerations

Patricia Moody1, Kevin Murtagh, Sarat Piduru

  • 1Department of Pathology and Cell Biology, University of South Florida, Tampa, FL, USA.

Insights

Tumor-to-tumor metastasis is rare, with meningiomas often being the recipient. This study details rare cases, including the first rectal adenocarcinoma metastasis to a meningioma.

Area of Science:

  • Oncology
  • Neuropathology

Background:

  • Tumor-to-tumor metastasis is an infrequent phenomenon, with fewer than 100 cases documented historically.
  • Meningiomas are the most common intracranial tumors to receive metastases, typically from lung or breast carcinomas.

Observation:

  • This case series presents three rare instances of tumor-to-tumor metastasis.
  • Includes the first reported case of rectal adenocarcinoma metastasis to a meningioma.
  • Details two cases of metastatic prostate adenocarcinoma to meningioma, a rare occurrence with only three prior published cases.

Findings:

  • Pathological details of these rare metastases are discussed.
  • Standard imaging (CT, MR) limitations in identifying metastasis within meningiomas are highlighted.
  • Physiology-based neuroimaging (perfusion MR, MR spectroscopy) shows potential for noninvasive differentiation of tumor histology.

Implications:

  • Expands the known spectrum of donor tumors in tumor-to-tumor metastasis.
  • Suggests advanced neuroimaging techniques may improve diagnostic accuracy for intracranial metastases.
  • Contributes to understanding rare oncological and neuropathological events.